baber/WOPTO huggingface dataset:
Patent NZ-515439-A (NZ)
Title: Method and plant for treating milk
Inventor: NISSEN ORLA
IPC: A23C9/142
Filed: 2000-05-31
Abstract: A plant and method of treating low-fat milk, such as skim milk, so as to obtain a milk with a low content of spores and bacteria, wherein the milk is subjected to a first microfiltration causing a separation into a first retentate and first permeate, the first permeate being subjected to an additional microfiltration. This double microfiltration ensures that the acceptable limits for bacterial counts in milk products are not exceeded in case of a membrane breakdown.
Patent NZ-515755-A (NZ)
Title: Synthesis of copolymers containing anhydrofructose derivatives
Inventor: GLUMER ANKE
IPC: C07D309/32
Filed: 2000-10-12
Abstract: A composition comprising at least two different polymerisable monomers (1) the first monomer unit is a polymerisable functionally equivalent derivative of anhydrofructose, for example of Formula A where R1 and R2 are independently selected from -OH, =O, R3 is a substituent comprising an -)H group and R4 and R5 are independently selected from -OH, =O or represent a bind with an adjacent atom on the ring of the cyclic compound wherein at least one of R4 and R5 represent a bond with an adjacent atom on the ring of the cyclic compound; and (2) the second monomer unit is other than a polymerisable functionally equivalent derivative of anhydrofructose. The polymerized composition forms a hydrogel which is useful as the absorbent product in nappies.
Patent NZ-516442-A (NZ)
Title: Peptides containing N-substituted D-amino acids for preventing beta-strand association
Inventor: STOTT KELVIN
IPC: C07K14/47
Filed: 2000-07-28
Abstract: A chemical compound or composition comprising a peptide, which peptide comprises a ß-strand-forming section of peptide which forms a ß-strand having two edges, a first edge which associates with a target ß-strand formed by a separate peptide-containing molecule, and a second edge, wherein the ß-strand-forming section of peptide comprises a sequence of at least four consecutive a-D-amino-acid residues, all of which sterically permit the ß-strand- forming section of peptide to form a ß-strand, and at least one of which is an Ná substituted á-D-amino-acid residue, and any two successive Ná-substituted á-D-amino-acid residues are separated by an odd number of consecutive Ná- unsubstituted á-D-amino-acid residues, such that the Ná- substituents lie along only the second edge. Said compounds can also be used to refold denatured or aggregated proteins.
Patent NZ-517237-A (NZ)
Title: 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
Inventor: PEVARELLO PAOLO
IPC: C07D231/40
Filed: 2000-05-05
Abstract: Compounds which are 3-amino-pyrazole derivatives represented by formula (I) wherein R is C3-C6 cycloalkyl group optionally substituted by a straight or branched C1- C6 alkyl or arylalkyl group; R1 is a straight or branched C1-C6 alkyl, C2-C4 alkenyl, cycloalkyl, cycloalkenyl, heterocyclyl, aryl, arylalkyl, arylcarbonyl, aryloxyalkyl or arylalkenyl group, each of which may be optionally further substituted as indicated in the description; or a pharmaceutically acceptable salt thereof. The compounds are useful for the treatment of cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto- immune diseases or neurodegenerative diseases.
Patent NZ-517408-A (NZ)
Title: A combination of viscosity enhancing agents and dispersion agents for use in reinforced cement building products
Inventor: GOODWIN PETER COLE
IPC: C04B24/26
Filed: 2000-08-24
Abstract: Described is a method and an agent for treating a cementitious material for extrusion, comprising adding to the cementitious material a viscosity enhancing agent and a dispersion agent in a quantity sufficient to increase the efficacy of the viscosity enhancing agent. By increasing the efficacy of the viscosity enhancing agent, extrudability may be maintained with less viscosity enhancing agent or a lower grade, i.e. cheaper viscosity enhancing agent than is conventionally used, or the extrudability may be improved for the same quantity of viscosity enhancing agent compared to a conventional dosage.
Patent NZ-520078-A (NZ)
Title: Pharmaceutical compositions comprising melatonin and an anti-hypertensive used to treat hypertension, vigilance and postponement of peak cortisol level
Inventor: ZISAPEL NAVA
IPC: A61K31/4045
Filed: 2000-01-05
Abstract: A pharmaceutical formulation, including both melatonin and at least one antihypertensive compound is described, in addition to a method, for treating a patient who is resistant to antihypertensives in absence of melatonin, a method for lowering nocturnal blood pressure in patients who have an abnormal rhythm in blood pressure in the absence or presence of antihypertensives, and a method for imparting in a patient at least one effect selected from improvement in mood and daytime vigilance, postponement of the peak level of cortisol in the patient and potential prophylactic protection against the detrimental effects of ischemia on the heart.
Patent NZ-520458-A (NZ)
Title: Caspase activated prodrugs therapy
Inventor: CARTER PAUL J
IPC: A61K47/48
Filed: 2001-02-22
Abstract: A method for the delivery of an active agent to a cell type of interest in vitro comprising the steps of: (a) administering an effective amount of a cell type targeted conjugate comprising a caspase which converts a caspase convertible pro-agent to an active agent and (b) administering a caspase convertible pro-agent.
Patent NZ-522581-A (NZ)
Title: Method of operating a wind power station and a wind power station regulated in dependence upon network frequency
Inventor: WOBBEN ALOYS
IPC: H02J3/40
Filed: 2001-03-31
Abstract: The present invention concerns a method of operating a wind power installation having an electrical generator drivable by a rotor for delivering electrical power to an electrical network to which the wind power installation is connected. The invention further concerns a wind power installation comprising a rotor and an electrical generator coupled to the rotor for delivering electrical power to an electrical consumer, in particular an electrical network. The object of the present invention is to eliminate the above-described problems when wind power installations are connected to the electrical network. A method of operating a wind power installation having a generator for delivering electrical power to an electrical network characterised in that the power delivered to the network by the generator is regulated or adjusted in dependence on the network frequency of the electrical network.
Patent NZ-525775-A (NZ)
Title: Ribbed tube continuous flexible spacer assembly
Inventor: DRDA PATRICK A
IPC: G06Q20/00
Filed: 2001-06-06
Abstract: A spacer assembly (18) is disclosed having a spacer (22) with a cross-section varying in a repeating manner along a longitudinal axis and an adhesive sealant (20) at least partially encapsulating the spacer (22). Also, a moisture vapor barrier may be provided as well as a desiccated topcoat (26).
Patent NZ-528205-A (NZ)
Title: Cell-based detection and differentiation of disease status in a cytological sample using a panel comprising a plurality of probes
Inventor: PRESSMAN NORMAN J
IPC: C12N5/08
Filed: 2002-03-12
Abstract: Described is a method for detecting and differentiating disease states with high sensitivity and specificity. The method allows for a determination of whether a cell-based sample contains abnormal cells and, for certain diseases, is capable of determining the histological type of disease present. The method detects changes in the level and pattern of expression of the molecular markers in the cell-based sample. Panel selection and validation procedures are also provided.
Patent NZ-529490-A (NZ)
Title: Pharmaceutical compositions of adsorbates of amorphous drug
Inventor: BABCOCK WALTER CHRISTIAN
IPC: A61P31/04
Filed: 2002-05-21
Abstract: A pharmaceutical composition comprising a low-solubility drug adsorbed onto a high surface area substrate to form an adsorbate is disclosed, wherein the pharmaceutical composition comprises a solid adsorbate comprising a low-solubility drug adsorbed onto a substrate to form an adsorbate, the substrate having a surface area of at least 20 m2/g, wherein at least a major portion of the drug in the adsorbate is amorphous; wherein the adsorbate provides improved concentration of the drug in a use environment relative to a slow-evaporation control composition comprising the drug and the substrate but formed by evaporation of solvent from a suspension of the drug in a solvent with the substrate suspended therein, the evaporation of the solvent for formation of the slow-evaporation control composition being conducted over a period of at least 30 minutes. Optionally, these compositions may also include a concentration-enhancing polymer.
Patent NZ-531770-A (NZ)
Title: An ironing board
Inventor: MULJADI BASUKI
IPC: D06F73/00
Filed: 2002-09-12
Abstract: An ironing board includes a support (1) and an ironing surface (2) having a substantially convex shape, the ironing surface (2) being movably mounted to the support (1) to allow the ironing surface (2) to be moved between first (2A) and second (2B) substantially perpendicular ironing positions.
Patent NZ-534585-A (NZ)
Title: Laser level including a pendulum, laser diodes, and lenses for converting laser beams into planar beams
Inventor: MARSHALL JAMES D
IPC: G01C15/10
Filed: 2004-08-09
Abstract: A laser level disposable on a reference surface includes a housing, a pendulum pivotably connected to the housing, a first laser diode disposed on the pendulum for emitting a first laser beam along a first path, a first lens disposed on the pendulum in the first path for converting the first laser beam into a first planar beam, the first planar beam forming a first line on the reference surface, a second laser diode disposed on the pendulum for emitting a second laser beam along a second path, and a second lens disposed on the pendulum in the second path for converting the second laser beam into a second planar beam, the second planar beam forming a second line on the reference surface, wherein the first and second lines are substantially perpendicular and non-intersecting.
Patent NZ-537735-A (NZ)
Title: Compositions of hyaluronic acid and methods of use
Inventor: SVIRKIN YURI
IPC: A61K47/10
Filed: 2003-07-03
Abstract: Compositions for the treatment of disorders characterized by dryness including dry eye and dry mouth are disclosed, wherein the compositions commonly comprise a conjugate of hyaluronic acid and polylysine. These conjugates are attached to affected body tissues or surfaces using transglutaminase, and preferably endogenous transglutaminase.
Patent NZ-538935-A (NZ)
Title: New 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: DE NANTEUIL GUILLAUME
IPC: A61P43/00
Filed: 2005-03-18
Abstract: A compound of formula (I), methods of manufacture and uses in the manufacture of a medicament to treat diseases such as angina, disorders of thrombotic origin, myocardial infarction and venous diseases.
Patent NZ-539094-A (NZ)
Title: Vehicle licence plates monitoring system
Inventor: GARIBOTTO GIOVANNI
IPC: G08G1/054
Filed: 2003-09-19
Abstract: A territorial surveillance and/or security control system based on monitoring vehicle license plates is disclosed. The system has a number of mobile surveillance units 2 for reading vehicle license plates and generating alarms during patrol, and a permanent surveillance centre 3 that communicates with the mobile units. The surveillance centre 3 locates the mobile surveillance units by radio to gather, file and consult the license plates detected, handles any alarms generated by the mobile units, and also updates a list of wanted license plates. Each mobile surveillance unit 2 includes a vehicle 4 equipped with a navigation system 5 and a license plate reading device 6. An alarm is generated immediately if a licence plate on the wanted list is spotted.
Patent NZ-539683-A (NZ)
Title: Microcell electrochemical devices and assemblies, and method of making and using the same
Inventor: ESHRAGUI RAY
IPC: H01M50/469
Filed: 2001-07-23
Abstract: A fibrous microcell structure that has at least one electrically conductive fibrous element surrounded by a porous membrane separator is disclosed. A first electrolytic layer having an electrically conductive hydrogen- or oxygen-permselective membrane is coated, impregnated or extruded on an inner surface of the porous membrane separator and an electrolyte is disposed in porosity of the porous membrane separator. The structure includes a central lumen including the fibrous element(s) and interstitial volume accommodating flow of feed through the lumen. The porous membrane separator also has an outer surface in contact with an electrocatalyst and at least one electrically conductive fiber.
Patent NZ-541158-A (NZ)
Title: Vitamin D3 lactone derivative
Inventor: TAKENOUCHI KAZUYA
IPC: A61P17/00
Filed: 2004-01-29
Abstract: Disclosed is a vitamin D3 lactone derivative of formula (1), wherein the substituents are as defined in the specification. The compounds are useful as therapeutic agents for treatment of hypercalcemia and Paget's disease. Also disclosed are compounds of formulae (4), (4syn) and (4anti), which are useful intermediates for compounds of formula (1), and processes for their preparation.
Patent NZ-549529-A (NZ)
Title: Microbiological processes for the production of 7alpha-substituted 11alpha-hydroxy steroids
Inventor: ZORN LUDWIG
IPC: C07J11/00
Filed: 2003-07-24
Abstract: Disclosed are 7-alpha-substituted 11-alpha-hydroxy steroids of formula (8,10,12), wherein the variables are as defined in the specification. Methods for the production of these steroids of formula (8,10,12) are also disclosed. (62) Divided Out of 537871
Patent NZ-553366-A (NZ)
Title: Inhaler for powdered, particularly medical substances with a movable dosing chamber with a closure side element
Inventor: VON SCHUCKMANN ALFRED
Filed: 2005-08-19
Abstract: An inhaler 1 for powdery substances, including a mouthpiece 3 and a suction air channel 12 leading to the mouthpiece 3, a storage chamber 11 for storing therein the powdery substance, a movable dosing chamber 26 for apportioning a specific amount of substance from the storage chamber 11 and moving an amount of substance into a ready position for transferring the amount of substance to a suction air stream, a closure slide element disposed to close off the dosing chamber 26 in the ready position, and movable relative to a dipping plunger into a dose-release position upon application of a preset minimum suction underpressure.
Patent NZ-554555-A (NZ)
Title: Cyclohexyl-urea derivatives as improved inhibitors for the soluble epoxide hydrolase
Inventor: HAMMOCK BRUCE D
IPC: C07D207/50
Filed: 2005-10-20
Abstract: Disclosed are cyclohexyl-urea derivatives as represented by the general formula: R1-P1-L1-P2-L2-(P3)m; wherein R1 represents a substituted or unsubstituted adamantyl, cyclohexyl or phenyl group; P1 is NHC(O)NH-; L1 is a substituted or unsubstituted cyclohexylene group; L2 is a linker as defined herein; P2 is a secondary pharmacophore selected from the group consisting of -NH-, -C(O)-, -CH(OH)-, -O(CH2CH2O)q-, -C(O)O-, -OC(O)-, -NHC(NH)NH-, -NHC(NH)CH2-, -CH2C(NH)NH-, -NHC(O)NH-, -OC(O)NH-, -NHC(O)O-, -C(O)NH-, -NHC(O)- and -NHC(S)NH-; P3 is a tertiary pharmacophore as defined herein; q is 0 to 6; and the subscript m is 0 or 1. Further disclosed are medicaments which comprise a compound as defined above for treating diseases modulated by soluble epoxide hydrolases in a subject in need of such treatment; wherein said disease is selected from the group consisting of hypertension, inflammation, adult respiratory distress syndrome; diabetic complications; end stage renal disease; Raynaud syndrome and arthritis.
Patent NZ-560529-A (NZ)
Title: Ultrasound diagnosis and treatment apparatus
Inventor: BURTON DAVID
IPC: G01N29/26
Filed: 2006-05-12
Abstract: Apparatus for imaging or treatment of occlusions or restrictions in vessels using sound waves is provided. The apparatus includes: at least one servo-controlled sound transducer member including at least one sound-emitting element for producing at least one sound wave beam, the sound transducer member controlled by a feedback control signal originating from an occlusion in fluid flow, a restriction in fluid flow, or a combination thereof; means to adjust the parameters of the at least one sound wave beam; means to spatially locate the at least one sound-emitting element; means to automatically or semi-automatically focus sound waves generated by the at least one sound-emitting element into a beam; and means to accept sound signals from the sound-emitting element or elements.
Patent NZ-563846-A (NZ)
Title: A drug delivery system for delivering active substances dispersed in a dispersion medium
Inventor: BAR-SHALOM DANIEL
IPC: A61K9/28
Filed: 2006-06-02
Abstract: A solid pharmaceutical composition in the form of a single dosage unit for oral use, the composition comprising a first and second fraction, the first fraction comprises a therapeutically and/or prophylactically active substance dispersed in a dispersion medium that is sufficiently fluid at body temperature and the second fraction comprises a matrix comprising a substantially water soluble and/or crystalline polymer or a mixture of substantially water soluble and/or crystalline polymers, the first fraction being included in the composition in such a manner that at least a part of the second fraction is firstly exposed to the gastrointestinal fluids upon administration before the first fraction becomes exposed. The system is designed to release the active substance after a predetermined period of time after administration, and the release of the active substances at that point in time is relatively fast.
Patent NZ-564178-A (NZ)
Title: Method for producing polyoxymethylene dimethyl ethers from methanol and formaldehyde
Inventor: STROEFER ECKHARD
IPC: C07C41/56
Filed: 2006-06-12
Abstract: A process for preparing tri- and tetraoxymethylene glycol dimethyl ether (POMDMEn=3,4) by reacting formaldehyde with methanol and subsequently working up the reaction mixture by distillation is disclosed, wherein the process comprises the steps of: a) feeding aqueous formaldehyde solution and methanol into a reactor and reacting to give a mixture a comprising formaldehyde, water, methylene glycol (MG), polyoxymethylene glycols (MGn>1), methanol, hemiformals (HF), methylal (POMDMEn=1) and polyoxymethylene glycol dimethyl ethers (POMDMEn>1); b) feeding the reaction mixture a into a reactive evaporator and separating into a low boiler fraction b1 comprising formaldehyde, water, methanol, methylene glycol, polyoxymethylene glycols, hemiformals, methylal and polyoxymethylene glycol dimethyl ethers (POMDMEn>1), and a high boiler fraction b2 comprising polyoxymethylene glycols, hemiformals (HFn>1) and polyoxymethylene glycol dimethyl ethers (POMDMEn>3), and recycling the high boiler fraction b2 into the reactor (step a)); c) feeding the low boiler fraction b1 into a first distillation column and separating into a low boiler fraction c1 comprising formaldehyde, water, methylene glycol, methanol, hemiformals, methylal, di-, tri- and tetraoxymethylene glycol dimethyl ether (POMDMEn=2,3,4), and a high boiler fraction c2 comprising polyoxymethylene glycols, high-boiling hemiformals (HFn>1) and high-boiling polyoxymethylene glycol dimethyl ethers (POMDMEn>4), and recycling the high boiler fraction c2 into the reactive evaporator (step b)); d) feeding the low boiler fraction c1 into a second distillation column and separating into a low boiler fraction d1 comprising formaldehyde, water, methanol, polyoxymethylene glycols, hemiformals, methylal and dioxymethylene glycol dimethyl ether methylene glycol, polyoxymethylene glycols, tri- and tetraoxymethylene glycol dimethyl ether (POMDMEn=3,4); e) feeding the high boiler fraction d2 into a phase separation apparatus and separating into an aqueous phase e1 substantially consisting of formaldehyde, water, methylene glycol and polyoxymethylene glycols, and an organic phase e2 comprising tri- and tetraoxymethylene glycol dimethyl ether (POMDMEn=3,4); f) feeding the organic phase e2 into a third distillation column and separating into a low boiler fraction f1 substantially consisting of formaldehyde, water, methylene glycol and polyoxymethylene glycols, and a high boiler fraction f2 substantially consisting of tri- and tetraoxymethylene glycol dimethyl ether (POMDMEn=3,4); and g) optionally feeding the aqueous phase e1 into a fourth distillation column and separating into a low boiler fraction g1 substantially consisting of formaldehyde, water, methylene glycol and polyoxymethylene glycols, and a high boiler fraction substantially consisting of water.
Patent NZ-565772-A (NZ)
Title: Monocoque construction method for skateboards or other
Inventor: NELSON LARRY
IPC: A63C17/01
Filed: 2008-02-08
Abstract: A monocoque structure using a stressed structural skin of sheet metal or other sheet material as the primary structure of a skating device, either self powered or motorised, or of a scooter, either self powered or motorised, the skin consisting very broadly of a bottom surface, with its dimension that is parallel to the direction of the skating device's or scooter's travel, in other words its length, greater than its dimension at right angles to this, in other words its width, a top surface, slightly shorter in length but of the same width, two side surfaces, two vertical end surfaces, two sloping end surfaces and a narrow raised central section, wherein the heights of the two side surfaces are forty percent or more of the width of the top and bottom surfaces and wherein the heights of the two vertical end surfaces together with the two sloping end surfaces and the height of the raised central section are seventy seven percent or more of the width of the top and bottom surfaces and with one or a plurality of pressed strengthening folds of an oval shape F, which is basically an elliptical shape, pressed into the sheet metal or other sheet material of the skin, and wherein when in the planar surfaces, that is surfaces of or relating to, in the form of, a plane, are there to prevent bending from an original and required flat plane and when in the curved surfaces are there to prevent an adverse increase in the degree of curvature bringing about a collapsing of the top surface towards the bottom surface, the pressed strengthening folds bringing about an increase in the overall strength of the skin but more importantly holding the skin correctly in station for maximum load bearing, the particular forming method of the folds eliminating the need for either stretching or shrinking of the sheet metal or other sheet material and producing an effective equivalent of a double curvature in the portion of skin contained within the bounds of the ovals without such stretching or shrinking. (61) Addition to 534817
Patent NZ-569375-A (NZ)
Title: Novel glycolipid adjuvant compositions
Inventor: DOMINOWSKI PAUL JOSEPH
IPC: A61K39/39
Filed: 2007-01-15
Abstract: Disclosed are compositions and methods of preparing stable adjuvant stock solutions and final adjuvant solutions comprising glycolipids of formula (I), weak acids, alcohols, non-ionic surfactants and buffers.
Patent NZ-572328-A (NZ)
Title: High concentration topical insecticides containing pyrethroids
Inventor: COTTRELL IAN W
IPC: A01N43/36
Filed: 2007-04-27
Abstract: Disclosed is an insecticide formulated by combining: an insecticidably effective amount of permethrin; an insecticidably effective amount of dinotefuran; an effective amount of pyriproxyfen; and an effective amount of a solvent component comprising N-octyl pyrrolidone and N-methyl pyrrolidone. The insecticide preparation has enhanced insecticidal activity against fleas and ticks while advantageously minimizing the total amount of insecticide needed for its effectiveness, and it is suitable for topical use because it is safe to use and avoids many common deleterious side effects of conventional topical insecticides.